Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: Review of the current data

Annals of Allergy, Asthma and Immunology

Volumn 111, Issue 6 SUPPL., 2013, Pages S2-

  Ballow, Mark ^a,b  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; BACTERIAL INFECTION; COMMON VARIABLE IMMUNODEFICIENCY; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; FOLLOW UP; HEALTH CARE MANAGEMENT; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INCIDENCE; INFECTION PREVENTION; PNEUMONIA; PRIMARY IMMUNODEFICIENCY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REIMBURSEMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; THERAPY EFFECT; X LINKED AGAMMAGLOBULINEMIA;

EID: 84888337717     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.06.013     Document Type: Review

References (17)

1. E.A. Goddard Intravenous immunoglobulin Curr Allergy Clin Immunol 21 2008 26 31
2. P.L. Yong, J. Boyle, and M. Ballow Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology Clin Immunol 135 2 2010 255 263
3. H.S. Hernandez-Trujillo, H. Chapel, and V. Lo Re III Comparison of American and European practices in the management of patients with primary immunodeficiencies Clin Exp Immunol 169 2012 57 69
4. J.S. Orange, W.J. Grossman, R.J. Navickis, and M.M. Wilkes Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies Clin Immunol 137 2010 21 30
5. M. Lucas, M. Lee, and J. Lortan Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years J Allergy Clin Immunol 125 2010 1354 1360.e4
6. V.R. Bonagura, R. Marchlewski, A. Cox, and D.W. Rosenthal Biological IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection J Allergy Clin Immunol 122 2008 210 211
7. S. Khan, B. Grimbacher, and C. Boecking Serum trough IgG level and annual intravenous immunoglobulin dose are not related to body size in patients on regular replacement therapy Drug Metab Lett 5 2011 132 136
8. I. Quinti, A. Soresina, and A. Guerra Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study J Clin Immunol 31 2011 315 322
9. H.M. Chapel, G.P. Spickett, and D. Ericson The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy J Clin Immunol 20 2000 94 100 (Pubitemid 30314313)
10. A. Gardulf, V. Andersen, and J. Bjorkander Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs Lancet 345 1995 365 367
11. A. Gardulf, U. Nicolay, and D. Math Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home J Allergy Clin Immunol 114 2004 936 942 (Pubitemid 39330270)
12. M. Berger Subcutaneous immunoglobulin replacement in primary immunodeficiencies Clin Immunol 112 2004 1 7 (Pubitemid 38781052)
13. S. Skoda-Smith, T.R. Torgerson, and H.D. Ochs Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease Ther Clin Risk Manag 6 2010 1 10
14. M. Berger, M. Rojavin, P. Kiessling, and O. Zenker Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies Clin Immunol 138 2011 133 141
15. J.S. Orange, B.H. Belhoradsky, and M. Berger Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy Clin Exp Immunol 169 2012 172 181
16. M. Berger, E. Murphy, and P. Riley Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G South Med J 103 2010 856 863
17. M. Berger Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD J Clin Immunol 31 5 2011 924 926